abstract |
Methods and uses for a pharmaceutical composition with an erythropoietin or a tissue protective cytosine are provided to protect or restore function for a cell, tissue, sensitive organ or the function or viability of a body part in mammals when administered outside the Therapeutic window of the previously approved therapeutics. |